As one of the largest healthcare services groups in Asia, Zuellig Pharma aims to strengthen its presence across Asia, saying it has acquired a controlling stake in Alliance Pharma (Cambodge), a leading healthcare distributor of Cambodia.
Financial terms of the deal were not disclosed.
Alliance Pharma (Cambodge) has been providing international healthcare companies with a full range of services designed to facilitate access to the Cambodian market since 2001.
Over the years, Alliance Pharma (Cambodge) has developed a full-scale WHO-GSDP certified distribution infrastructure for vaccines, cold-chain products as well as pharmaceutical products, operated by around 400 experts in distribution and sales & marketing.
“We are excited to grow our presence in Cambodia. This acquisition will give Zuellig Pharma a market-leading position in Cambodia, strengthen our presence in Indochina and offer a great platform for accelerated growth in Cambodia and in the region for Zuellig Pharma and its clients,” said Yves Hermes, area director for Southeast Asia for Zuellig Pharma.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze